Skip to content
Search

Latest Stories

PSNC disappointed as CPCF annual review ends without funding boost

The Pharmaceutical Services Negotiating Committee (PSNC) has expressed disappointment as the government continued to refuse to “a much-needed broader funding uplift” for the community pharmacies in England.

This follows conclusion of the first Annual Review of the progress of the five-year Community Pharmacy Contractual Framework (CPCF) deal by PSNC, the Department of Health and Social Care (DHSC) and NHS England & NHS Improvement (NHSE&I).


“We remain deeply frustrated by government’s refusal to agree a much-needed broader funding uplift for the sector, but we are determined to continue to look for better ways forward for the sector throughout 2022 and beyond,” said Bharat Patel, PSNC vice-chair, negotiating team member and an independent contractor.

Patel noted that despite some important wins such as recognition of key challenges faced by pharmacies, the commitment to consider these as part of our Year 4 negotiations, and agreement to take forward work on service fee and other regulatory changes, the PSNC is disappointed that the review did not lead to “immediate and tangible outcomes and improvements for contractors.”

The negotiator had put forward data and analysis showing the capacity and cost constraints faced by pharmacies.

Mike Dent, PSNC director of Pharmacy Funding, said: “Our data also provides useful evidence to support ongoing discussions about the extraordinary performance and value of pharmacies”.

“PSNC is now working to build on the outputs of the review in the upcoming Year 4 negotiations: we will be gathering and analysing more data to support our discussions, as well as continuing to highlight the pressures on the sector, and exploring ways to bid again for additional funding over the course of this year.”

Tricia Kennerley, PSNC negotiating team member and VP, director International Public Affairs at Walgreens Boots Alliance, said that situation for contractors continues to worsen.

She added that PSNC has clearly stated “the immense pressures the sector is facing”, which is important ahead of “another critical round of discussions for the sector, with many contractors simply unable to take on any further services without additional funding, support and access to the right staff.”

Reacting to the review outcome, the National Pharmacy Association chief executive Mark Lyonette said: “It appears this annual contract review has rubber-stamped another year of cuts for pharmacies across England.

“This is an insult to pharmacy teams, who have worked relentlessly hard to help keep the country on its feet during the Covid pandemic."

He added that high costs, increased public demand for pharmacy support have increased pressures and demotivated many staff.

“Instead of moving forwards into new clinical roles, which the NHS and DHSC say they want, pharmacies could now slip back, focus narrowly on dispensing and reduce access to care – the very opposite of the aspirations stated in the NHS Plan.

“Governments, NHS and negotiators elsewhere in the UK are working to agreed visions and decently funded strategies. England should follow suit and jettison the nonsense that great services can be provided on a shorter and shorter shoestring.”

Meanwhile, PSNC stated that all parties have agreed to:

  • Recognise the capacity constraints within the sector in the upcoming Year 4 negotiations;
  • Explore the scale and impact of the more complex consultations now taking place in community pharmacy – the Pharmacy Advice Audit begins this process;
  • Continue and conclude discussions on services fee setting principles; and
  • Consider measures for assessing capacity within community pharmacies.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less